AGP Executive Report
Last update: 4 hours agoObesity Drug Watch: AstraZeneca says its experimental once-daily oral weight-loss pill elecoglipron delivered dose-dependent results in a Phase 2 trial, with the top dose averaging 10.5% weight loss after 26 weeks versus 0.6% on placebo, raising the stakes in the race for easier-to-take GLP-1-style obesity treatments. Light Pollution & Health: A Nature study using NASA satellite images reports light pollution fell in Europe overall and dropped sharply in France (-33%), tied to street-lighting policies aimed at protecting nocturnal biodiversity and cutting energy use, while researchers note sleep-impact risks remain a concern. Global Alcohol Shift: IWSR data shows spirits overtook wine in global volume for the first time since 1990, while no- and low-alcohol beer is expected to double its share of the beer market by 2033. Hospitality & Food Culture: A travel piece highlights “clean plate” norms across much of Europe versus different expectations in China, plus guidance on dining etiquette to avoid awkward moments abroad. World Cup Food & Drink Angle: Coverage from Houston and beyond focuses on match-day logistics and fan culture, with stadium and venue changes shaping what visitors eat and drink during the tournament.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.